Epigallocatechin-3-gallate ameliorates hyperglycemia-induced embryonic vasculopathy and malformation by inhibition of Foxo3a activation

American Journal of Obstetrics and Gynecology

Volumn 203, Issue 1, 2010, Pages 75.e1-75.e6

  Yang, Peixin ^a   Li, Hua ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Akt activation; epigallocatechin 3 gallate; Foxo3a activation; hyperglycemia; malformations; vasculopathy

Indexed keywords

EPIGALLOCATECHIN GALLATE; GLUCOSE; PROTEIN KINASE B; TRANSCRIPTION FACTOR FKHRL1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; EMBRYOPATHY; ENZYME ACTIVATION; HYPERGLYCEMIA; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION;

EID: 77953914068     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2010.02.008     Document Type: Article

References (25)

1. Lawrence J.M., Contreras R., Chen W., and Sacks D.A. Trends in the prevalence of preexisting diabetes and gestational diabetes mellitus among a racially/ethnically diverse population of pregnant women, 1999-2005. Diabetes Care 31 (2008) 899-904
2. Correa A., Gilboa S.M., Besser L.M., et al. Diabetes mellitus and birth defects. Am J Obstet Gynecol 199 (2008) 237e1-9
3. Holing E.V., Beyer C.S., Brown Z.A., and Connell F.A. Why don't women with diabetes plan their pregnancies?. Diabetes Care 21 (1998) 889-895
4. Yang X., Borg L.A., and Eriksson U.J. Altered metabolism and superoxide generation in neural tissue of rat embryos exposed to high glucose. Am J Physiol 272 (1997) E173-E180
5. Yang X., Borg L.A., Siman C.M., and Eriksson U.J. Maternal antioxidant treatments prevent diabetes-induced alterations of mitochondrial morphology in rat embryos. Anat Rec 251 (1998) 303-315
6. Sakamaki H., Akazawa S., Ishibashi M., et al. Significance of glutathione-dependent antioxidant system in diabetes-induced embryonic malformations. Diabetes 48 (1999) 1138-1144
7. Sivan E., Lee Y.C., Wu Y.K., and Reece E.A. Free radical scavenging enzymes in fetal dysmorphogenesis among offspring of diabetic rats. Teratology 56 (1997) 343-349
8. Reece E.A., Wu Y.K., Zhao Z., and Dhanasekaran D. Dietary vitamin and lipid therapy rescues aberrant signaling and apoptosis and prevents hyperglycemia-induced diabetic embryopathy in rats. Am J Obstet Gynecol 194 (2006) 580-585
9. Guo Q., Zhao B., Li M., Shen S., and Xin W. Studies on protective mechanisms of four components of green tea polyphenols against lipid peroxidation in synaptosomes. Biochim Biophys Acta 1304 (1996) 210-222
10. Isbrucker R.A., Edwards J.A., Wolz E., Davidovich A., and Bausch J. Safety studies on epigallocatechin gallate (EGCG) preparations, part 3: teratogenicity and reproductive toxicity studies in rats. Food Chem Toxicol 44 (2006) 651-661
11. Xu Z., Chen S., Li X., Luo G., Li L., and Le W. Neuroprotective effects of (-)-epigallocatechin-3-gallate in a transgenic mouse model of amyotrophic lateral sclerosis. Neurochem Res 31 (2006) 1263-1269
12. Levites Y., Amit T., Youdim M.B., and Mandel S. Involvement of protein kinase C activation and cell survival/cell cycle genes in green tea polyphenol (-)-epigallocatechin 3-gallate neuroprotective action. J Biol Chem 277 (2002) 30574-30580
13. Yang P., Zhao Z., and Reece E.A. Activation of oxidative stress signaling that is implicated in apoptosis with a mouse model of diabetic embryopathy. Am J Obstet Gynecol 198 (2008) 130.e1-130.e7
14. Reece E.A., Ma X.D., Wu Y.K., and Dhanasekaran D. Aberrant patterns of cellular communication in diabetes-induced embryopathy, I: membrane signaling. J Matern Fetal Neonatal Med 11 (2002) 249-253
15. Yang P., Zhao Z., and Reece E.A. Involvement of c-Jun N-terminal kinases activation in diabetic embryopathy. Biochem Biophys Res Commun 357 (2007) 749-754
16. Reece E.A., Ma X.D., Zhao Z., Wu Y.K., and Dhanasekaran D. Aberrant patterns of cellular communication in diabetes-induced embryopathy in rats, II: apoptotic pathways. Am J Obstet Gynecol 192 (2005) 967-972
17. Yang P., Zhao Z., and Reece E.A. Blockade of c-Jun N-terminal kinase activation abrogates hyperglycemia-induced yolk sac vasculopathy in vitro. Am J Obstet Gynecol 198 (2008) 321.e1-321.e7
18. Reece E.A., Wiznitzer A., Homko C.J., Hagay Z., and Wu Y.K. Synchronization of the factors critical for diabetic teratogenesis: an in vitro model. Am J Obstet Gynecol 174 (1996) 1284-1288
19. Brunet A., Bonni A., Zigmond M.J., et al. Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor. Cell 96 (1999) 857-868
20. Winslow L.C., and Kroll D.J. Herbs as medicines. Arch Intern Med 158 (1998) 2192-2199
21. Isbrucker R.A., Bausch J., Edwards J.A., and Wolz E. Safety studies on epigallocatechin gallate (EGCG) preparations, part 1: genotoxicity. Food Chem Toxicol 44 (2006) 626-635
22. Isbrucker R.A., Edwards J.A., Wolz E., Davidovich A., and Bausch J. Safety studies on epigallocatechin gallate (EGCG) preparations, part 2: dermal, acute and short-term toxicity studies. Food Chem Toxicol 44 (2006) 636-650
23. Xie Y., Puscheck E.E., and Rappolee D.A. Effects of SAPK/JNK inhibitors on preimplantation mouse embryo development are influenced greatly by the amount of stress induced by the media. Mol Hum Reprod 12 (2006) 217-224
24. Zhao Z., Yang P., Eckert R.L., and Reece E.A. Caspase-8: a key role in the pathogenesis of diabetic embryopathy. Birth Defects Res B Dev Reprod Toxicol 86 (2009) 72-77
25. Cai E.P., and Lin J.K. Epigallocatechin gallate (EGCG) and rutin suppress the glucotoxicity through activating IRS2 and AMPK signaling in rat pancreatic beta cells. J Agric Food Chem 57 (2009) 9817-9827